Embryonic mesencephalic transplantation for the treatment of Parkinson's disease

BlueCross BlueShield Association
Record ID 32003000734
Authors' objectives:

The objective of this Assessment is to determine whether the transplantation of embryonic mesencephalic-derived dopamine-producing cells to the corpus striatum improves the health outcomes of patients with advanced Parkinson's disease.

Authors' methods: Systematic review
Project Status: Completed
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Mesencephalon
  • Parkinson Disease
  • Transplantation
Organisation Name: BlueCross BlueShield Association
Contact Address: BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name: tec@bcbsa.com
Contact Email: tec@bcbsa.com
Copyright: BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.